Hudson Biotech
Hudson Biotech
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity | Body Weight, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, nutritional disorder, obesity disorder, overnutrition, prediabetes syndrome | Recruiting | Phase 2 | 2026-04-01 | NCT07505745 | |
| TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD | Arterial Occlusive Diseases, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, vascular disorder | Recruiting | Phase 1 / Phase 2 | 2026-03-23 | NCT07487363 | |
| Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1) | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 3 | 2026-03-19 | NCT07481747 | |
| Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Recruiting | Phase 2 | 2026-03-19 | NCT07481734 | |
| Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 2 | 2026-03-12 | NCT07467447 | |
| Topical GHK-Cu Gel for Acute Skin Wound Healing | Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds) | Recruiting | Phase 2 | 2026-02-27 | NCT07437586 | |
| Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligo | Recruiting | Phase 2 | 2026-02-27 | NCT07437560 | |
| BPC 157 for Acute Hamstring Muscle Strain Repair | Sprains and Strains, injury | Recruiting | Phase 2 | 2026-02-27 | NCT07437547 |